Gene Transfer Research Oversight at Johns Hopkins

Gene Transfer Research Oversight at Johns Hopkins Medicine

Gene transfer research, particularly involving recombinant or synthetic nucleic acid molecules, is a rapidly advancing field with significant potential for therapeutic breakthroughs. However, this research also presents unique ethical, safety, and regulatory challenges. Johns Hopkins Medicine has established a comprehensive framework to ensure the responsible conduct of gene transfer research, involving multiple oversight bodies and strict adherence to federal and institutional guidelines.

Regulatory Framework and Oversight Bodies

The oversight of gene transfer research at Johns Hopkins Medicine is governed by a combination of federal regulations, institutional policies, and specialized committees. The primary oversight bodies include:

• Institutional Review Board (IRB): Ensures the protection of human subjects’ safety, rights, and welfare.
• Institutional Biosafety Committee (IBC): Reviews and monitors the biosafety aspects of research involving recombinant or synthetic nucleic acid molecules.
• Recombinant DNA Advisory Committee (RAC): Provides advisory review for gene transfer protocols, particularly those involving novel or high-risk approaches.

Role of the Institutional Review Board (IRB)

The IRB is responsible for reviewing and approving all research involving human subjects to ensure compliance with ethical standards and regulatory requirements. At Johns Hopkins Medicine, the IRB:

• Ensures that informed consent is obtained from all participants.
• Reviews the risks and benefits of the research.
• Monitors ongoing research to ensure continued compliance with ethical and regulatory standards.

Role of the Institutional Biosafety Committee (IBC)

The IBC is responsible for reviewing and monitoring the biosafety aspects of research involving recombinant or synthetic nucleic acid molecules. The IBC:

• Ensures that appropriate containment and safety measures are in place.
• Reviews the potential risks to researchers, healthcare workers, and the environment.
• Provides guidance on the safe handling and disposal of biological materials.

Role of the Recombinant DNA Advisory Committee (RAC)

The RAC provides advisory review for gene transfer protocols, particularly those involving novel or high-risk approaches. The RAC:

• Reviews protocols for scientific merit, safety, and ethical considerations.
• Provides recommendations to the IRB and IBC.
• Ensures that research is conducted in accordance with federal guidelines and institutional policies.

NIH Guidelines for Gene Transfer Research

The National Institutes of Health (NIH) has established guidelines for gene transfer research, which are applicable to all research conducted by or sponsored by institutions receiving NIH funding. These guidelines include:

• Requirements for IRB and IBC review.
• Procedures for RAC advisory review.
• Prohibitions on certain types of research, such as germ-line modification and in utero gene transfer.

Appendix M of the NIH Guidelines

Appendix M of the NIH Guidelines provides detailed information on the process and guidelines for information submission to the RAC for gene transfer protocols. Key points include:

• Protocols must be submitted for RAC review if they involve novel or high-risk approaches.
• The RAC will not accept protocols involving germ-line modification or in utero gene transfer.
• Completion of the RAC review process is compulsory for NIH-supported research.

IRB and IBC Approval Process

Before human subjects can be enrolled in a gene transfer research study, the protocol must be approved by both the IRB and IBC. The approval process includes:

• Submission of the research protocol to the IRB and IBC.
• Review of the protocol for ethical, safety, and regulatory compliance.
• Approval by both committees before research can proceed.

RAC Advisory Review

The RAC provides advisory review for gene transfer protocols, particularly those involving novel or high-risk approaches. The RAC review process includes:

• Submission of the protocol to the RAC.
• Review of the protocol for scientific merit, safety, and ethical considerations.
• Provision of recommendations to the IRB and IBC.
• Completion of the RAC review process is compulsory for NIH-supported research.

Compliance with Federal Regulations

Gene transfer research at Johns Hopkins Medicine must comply with federal regulations, including:

• The Common Rule (45 CFR 46).
• FDA regulations for investigational new drugs (21 CFR Parts 50 and 56).
• NIH guidelines for research involving recombinant or synthetic nucleic acid molecules.

Monitoring and Reporting

Ongoing monitoring and reporting are essential components of gene transfer research oversight. Researchers must:

• Submit regular progress reports to the IRB and IBC.
• Report any adverse events or protocol deviations.
• Ensure continued compliance with ethical and regulatory standards.

FAQs

What is gene transfer research?

Gene transfer research involves the deliberate transfer of recombinant or synthetic nucleic acid molecules into human subjects for therapeutic or research purposes.

Who oversees gene transfer research at Johns Hopkins Medicine?

Gene transfer research at Johns Hopkins Medicine is overseen by the Institutional Review Board (IRB), Institutional Biosafety Committee (IBC), and Recombinant DNA Advisory Committee (RAC).

What are the requirements for IRB and IBC approval?

Before human subjects can be enrolled in a gene transfer research study, the protocol must be approved by both the IRB and IBC. The approval process includes submission of the research protocol, review for ethical, safety, and regulatory compliance, and approval by both committees.

What is the role of the RAC?

The RAC provides advisory review for gene transfer protocols, particularly those involving novel or high-risk approaches. The RAC reviews protocols for scientific merit, safety, and ethical considerations and provides recommendations to the IRB and IBC.

What are the NIH guidelines for gene transfer research?

The NIH guidelines for gene transfer research include requirements for IRB and IBC review, procedures for RAC advisory review, and prohibitions on certain types of research, such as germ-line modification and in utero gene transfer.

What is Appendix M of the NIH Guidelines?

Appendix M of the NIH Guidelines provides detailed information on the process and guidelines for information submission to the RAC for gene transfer protocols. It includes requirements for RAC review, prohibitions on certain types of research, and procedures for completing the RAC review process.

What are the federal regulations for gene transfer research?

Gene transfer research at Johns Hopkins Medicine must comply with federal regulations, including the Common Rule (45 CFR 46), FDA regulations for investigational new drugs (21 CFR Parts 50 and 56), and NIH guidelines for research involving recombinant or synthetic nucleic acid molecules.

What is the monitoring and reporting process for gene transfer research?

Ongoing monitoring and reporting are essential components of gene transfer research oversight. Researchers must submit regular progress reports to the IRB and IBC, report any adverse events or protocol deviations, and ensure continued compliance with ethical and regulatory standards.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb